Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Ernest Mario, Pappas partner who steered Alza into J&J deal, passes away

“His counsel and legacy will always remain with us,” says Pappas team

By Paul Bonanos, Director of Biopharma Intelligence 
October 29, 2024 11:12 PM UTC

Pappas Ventures announced the passing of Senior Venture Partner Ernest Mario, a longtime biopharma executive who led and invested in biopharmas across several decades. He was 86.

Mario may have been best known for guiding delivery company Alza Corp. through its $12.3 billion acquisition by Johnson & Johnson (NYSE:JNJ) in 2001, a deal that was among the largest in pharma history when it took place. Before joining Alza in 1993, he had been CEO of Glaxo plc, now GSK plc (LSE:GSK; NYSE:GSK), for nearly four years...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Pappas Ventures